- Home
- ZCAR vs OGEN Comparison
ZCAR vs OGEN Comparison
Compare ZCAR & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- OGEN
- Stock Information
- Founded
- ZCAR 2013
- OGEN 1996
- Country
- ZCAR India
- OGEN United States
- Employees
- ZCAR N/A
- OGEN N/A
- Industry
- ZCAR Blank Checks
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ZCAR Finance
- OGEN Health Care
- Exchange
- ZCAR Nasdaq
- OGEN Nasdaq
- Market Cap
- ZCAR 10.7M
- OGEN 4.5M
- IPO Year
- ZCAR N/A
- OGEN N/A
- Fundamental
- Price
- ZCAR $6.14
- OGEN $0.34
- Analyst Decision
- ZCAR
- OGEN
- Analyst Count
- ZCAR 0
- OGEN 0
- Target Price
- ZCAR N/A
- OGEN N/A
- AVG Volume (30 Days)
- ZCAR 1.1M
- OGEN 389.1K
- Earning Date
- ZCAR 11-15-2024
- OGEN 11-07-2024
- Dividend Yield
- ZCAR N/A
- OGEN N/A
- EPS Growth
- ZCAR N/A
- OGEN N/A
- EPS
- ZCAR N/A
- OGEN N/A
- Revenue
- ZCAR $9,523,600.00
- OGEN $7,466.00
- Revenue This Year
- ZCAR N/A
- OGEN N/A
- Revenue Next Year
- ZCAR N/A
- OGEN N/A
- P/E Ratio
- ZCAR N/A
- OGEN N/A
- Revenue Growth
- ZCAR N/A
- OGEN N/A
- 52 Week Low
- ZCAR $5.72
- OGEN $0.29
- 52 Week High
- ZCAR $761.00
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- ZCAR 19.46
- OGEN 37.15
- Support Level
- ZCAR $0.13
- OGEN $0.29
- Resistance Level
- ZCAR $0.15
- OGEN $0.45
- Average True Range (ATR)
- ZCAR 0.01
- OGEN 0.04
- MACD
- ZCAR -0.01
- OGEN 0.02
- Stochastic Oscillator
- ZCAR 12.00
- OGEN 28.88
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.